{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:41:46Z","timestamp":1789213306322,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T00:00:00Z","timestamp":1299801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s13402-011-0011-2","type":"journal-article","created":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T14:53:36Z","timestamp":1299768816000},"page":"177-187","source":"Crossref","is-referenced-by-count":15,"title":["Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Tasneem","family":"Kausar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Raghibul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar K.","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddartha Datta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranju","family":"Ralhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,11]]},"reference":[{"key":"11_CR1","volume-title":"Globocan 2002: cancer incidence, mortality and prevelance worldwide, version 1.0, IARC cancer base no. 5","author":"IARC","year":"2005","unstructured":"IARC, Globocan 2002: cancer incidence, mortality and prevelance worldwide, version 1.0, IARC cancer base no. 5 (IARC Press, Lyon, 2005)"},{"key":"11_CR2","first-page":"53","volume":"2","author":"DM Parkin","year":"2001","unstructured":"D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Estimating the world cancer burden: Globocan 2000. Int J Cancer 2, 53\u20136 (2001)","journal-title":"Int J Cancer"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s005950170129","volume":"5","author":"NM Gupta","year":"2001","unstructured":"N.M. Gupta, R. Jindal, O. Prakash, R. Gupta, D.K. Bhasin, Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India. Surg Today 5, 400\u20134 (2001)","journal-title":"Surg Today"},{"key":"11_CR4","first-page":"63","volume":"30","author":"JWPM Baal Van","year":"2008","unstructured":"J.W.P.M. Van Baal, F. Milana, A.M. Rygiel, C.M.T. Sondermeijer, C.A. Spek, J.J.G.H. Bergman, M.P. Peppelenbosch, K.K. Krishnadath, A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma. Cell Oncol 30, 63\u201375 (2008)","journal-title":"Cell Oncol"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0888-7543(03)00023-5","volume":"8","author":"R Sharma","year":"2003","unstructured":"R. Sharma, S. Samantaray, N.K. Shukla, R. Ralhan, Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics 8, 481\u20138 (2003)","journal-title":"Genomics"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1542794","volume":"255","author":"DP Gearing","year":"1992","unstructured":"D.P. Gearing, M.R. Comeau, D.J. Friend, S.D. Gimpel, C.J. Thut et al., The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255, 1434\u20131437 (1992)","journal-title":"Science"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"32635","DOI":"10.1074\/jbc.271.51.32635","volume":"271","author":"B Mosley","year":"1996","unstructured":"B. Mosley, C. De Imus, D. Friend, N. Boiani, B. Thoma, L.S. Park, D. Cosman, Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271, 32635\u201332643 (1996)","journal-title":"J Biol Chem"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1158\/0008-5472.CAN-06-1766","volume":"66","author":"N Underhill-Day","year":"2006","unstructured":"N. Underhill-Day, J.K. Heath, M. Oncostatin, (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel. Cancer Res 66, 10891\u201310901 (2006)","journal-title":"Cancer Res"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.4049\/jimmunol.173.9.5343","volume":"173","author":"SJ Levine","year":"2004","unstructured":"S.J. Levine, Mechanisms of soluble cytokine receptor generation. J Immunol 173, 5343\u20135348 (2004)","journal-title":"J Immunol"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.4049\/jimmunol.148.7.2175","volume":"148","author":"M Honda","year":"1992","unstructured":"M. Honda, S. Yamamoto, M. Cheng, K. Yasukawa, H. Suzuki, T. Saito, Y. Osugi, T. Tokunaga, T. Kishimoto, Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 148, 2175\u20132180 (1992)","journal-title":"J Immunol"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1126\/science.7681218","volume":"259","author":"S Davis","year":"1993","unstructured":"S. Davis, T.H. Aldrich, N.Y. Ip, N. Stahl, S. Scherer, T. Farruggella, P.S. DiStefano, R. Curtis, N. Panayotatos, H. Gascan, S. Chevalier, G.D. Yancopoulos, Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. Science 259, 1736\u20131739 (1993)","journal-title":"Science"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.V82.4.1120.1120","volume":"82","author":"M Narazaki","year":"1993","unstructured":"M. Narazaki, K. Yasukawa, T. Saito, Y. Ohsugi, H. Fukui, Y. Koishihara, G.D. Yancopoulos, T. Taga, T. Kishimoto, Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82, 1120\u20131126 (1993)","journal-title":"Blood"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/MCB.9.7.2847","volume":"9","author":"N Malik","year":"1989","unstructured":"N. Malik, J.C. Kallestad, N.L. Gunderson, S.D. Austin, M.G. Neubauer, V. Ochs, H. Marquardt, J.M. Zarling, M. Shoyab, C.M. Wei, Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol 9, 2847\u20132853 (1989)","journal-title":"Mol Cell Biol"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.4049\/jimmunol.139.9.2977","volume":"139","author":"TJ Brown","year":"1987","unstructured":"T.J. Brown, M.N. Lioubin, H. Marquardt, Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. J Immunol 139, 2977\u20132983 (1987)","journal-title":"J Immunol"},{"key":"11_CR15","first-page":"1011","volume":"19","author":"S Mori","year":"1999","unstructured":"S. Mori, K. Murakami-Mori, B. Bonavida, M. Oncostatin, (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor. Anticancer Res 19, 1011\u20131015 (1999)","journal-title":"Anticancer Res"},{"key":"11_CR16","first-page":"74","volume":"145","author":"J Cai","year":"1994","unstructured":"J. Cai, P.S. Gill, R. Masood, P. Chandrasoma, B. Jung, R.E. Law, S.F. Radka, Oncostatin-M is an autocrine growth factor in Kaposi\u2019s sarcoma. Am J Pathol 145, 74\u20139 (1994)","journal-title":"Am J Pathol"},{"key":"11_CR17","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Tu\u00f1\u00f3n, M. Ricote, A. Ruiz, B. Fraile, R. Paniagua and M. Royuela, OSM, LIF, Its Receptors, and Its Relationship with the Malignance in Human Breast Carcinoma (In Situ and in Infiltrative), Cancer invest. 26 (2008), 222\u2013229.","DOI":"10.1080\/07357900701638491"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000087283","volume":"69","author":"R Sharma","year":"2005","unstructured":"R. Sharma, N. Sud, T.K. Chattopadhyay, R. Ralhan, TC21\/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications. Oncology 69, 10\u201318 (2005)","journal-title":"Oncology"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0014-5793(93)80507-Q","volume":"332","author":"J M\u00fcllberg","year":"1993","unstructured":"J. M\u00fcllberg, E. Dittrich, L. Graeve, C. Gerhartz, K. Yasukawa, T. Taga, T. Kishimoto, P.C. Heinrich, S. Rose-John, Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Lett. 332, 174\u2013178 (1993)","journal-title":"FEBS Lett."},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/eji.1830230226","volume":"23","author":"J M\u00fcllberg","year":"1993","unstructured":"J. M\u00fcllberg, H. Schooltink, T. Stoyan, M. G\u00fcnther, L. Graeve, G. Buse, A. Mackiewicz, P.C. Heinrich, S. Rose-John, The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23, 473\u2013480 (1993)","journal-title":"Eur J Immunol"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/0264-6021:3530663","volume":"353","author":"K Althoff","year":"2001","unstructured":"K. Althoff, J. M\u00fcllberg, D. Aasland, N. Voltz, K. Kallen, J. Gr\u00f6tzinger, S. Rose-John, Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem J 353, 663\u2013672 (2001)","journal-title":"Biochem J"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"10798","DOI":"10.1074\/jbc.273.17.10798","volume":"273","author":"JG Zhang","year":"1998","unstructured":"J.G. Zhang, Y. Zhang, C.M. Owczarek, L.D. Ward, R.L. Moritz, R.J. Simpson, K. Yasukawa, N.A. Nicola, Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J Biol Chem 273, 10798\u201310805 (1998)","journal-title":"J Biol Chem"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/jir.2005.25.241","volume":"25","author":"SA Jones","year":"2005","unstructured":"S.A. Jones, P.J. Richards, J. Scheller, S. Rose-John, IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res 25, 241\u2013253 (2005)","journal-title":"J Interferon Cytokine Res"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(99)00477-9","volume":"450","author":"S Pflanz","year":"1999","unstructured":"S. Pflanz, I. Tacken, J. Gr\u00f6tzinger, Y. Jacques, S. Minvielle, H. Dahmen, P.C. Heinrich, G. M\u00fcller-Newen, A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130. FEBS Lett 450, 117\u2013122 (1999)","journal-title":"FEBS Lett"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1006\/jmbi.2001.5282","volume":"315","author":"D Aasland","year":"2002","unstructured":"D. Aasland, B. Oppmann, J. Gr\u00f6tzinger, S. Rose-John, K.J. Kallen, The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex. J Mol Biol 315, 637\u2013646 (2002)","journal-title":"J Mol Biol"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"36673","DOI":"10.1074\/jbc.M607005200","volume":"281","author":"C Diveu","year":"2006","unstructured":"C. Diveu, E. Venereau, J. Froger, E. Ravon, L. Grimaud, F. Rousseau, S. Chevalier, H. Gascan, Molecular and functional characterization of a soluble form of oncostatin M\/interleukin-31 shared receptor. J Biol Chem 281, 36673\u201336682 (2006)","journal-title":"J Biol Chem"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/path.2361","volume":"215","author":"D Chen","year":"2008","unstructured":"D. Chen, C.Y. Chu, C.Y. Chen, H.C. Yang, Y.Y. Chiang, T.Y. Lin, I.P. Chiang, D.Y. Chuang, C.C. Yu, K.C. Chow, Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas. J Pathol 215, 290\u2013299 (2008)","journal-title":"J Pathol"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/molehr\/7.7.665","volume":"7","author":"Y Ohata","year":"2001","unstructured":"Y. Ohata, T. Harada, A. Fujii, S. Yoshida, T. Iwabe, N. Terakawa, Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M. Mol Hum Reprod 7, 665\u2013670 (2001)","journal-title":"Mol Hum Reprod"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.1471-4159.2001.00202.x","volume":"76","author":"M Friedrich","year":"2000","unstructured":"M. Friedrich, N. H\u00f6ss, F. St\u00f6gbauer, V. Senner, W. Paulus, E.B. Ringelstein, H. Halfter, Complete inhibition of in vivo glioma growth by oncostatin M. J Neurochem 76, 1589\u20131592 (2000)","journal-title":"J Neurochem"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-2230.2001.00765.x","volume":"26","author":"JC Szepietowski","year":"2001","unstructured":"J.C. Szepietowski, C. Walker, D.B. McKenna, J.A. Hunter, R.C. McKenzie, Leukaemia inhibitory factor and interleukin-8 expression in nonmelanoma skin cancers. Clin Exp Dermatol 26, 72\u201378 (2001)","journal-title":"Clin Exp Dermatol"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s004320050304","volume":"125","author":"J Liu","year":"1999","unstructured":"J. Liu, J.W. Li, Y. Gang, L. Guo, H. Li, Expression of leukemiainhibitory factor as an autocrinal growth factor in human medulloblastomas. J Cancer Res Clin Oncol 125, 475\u2013480 (1999)","journal-title":"J Cancer Res Clin Oncol"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO;2-6","volume":"66","author":"P Kellokumpu-Lehtinen","year":"1996","unstructured":"P. Kellokumpu-Lehtinen, M. Talpaz, D. Harris, Q. Van, R. Kurzrock, Z. Estrov, Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. Int J Cancer 66, 515\u2013519 (1996)","journal-title":"Int J Cancer"},{"key":"11_CR33","doi-asserted-by":"crossref","first-page":"25273","DOI":"10.1074\/jbc.M002296200","volume":"275","author":"Y Wang","year":"2000","unstructured":"Y. Wang, O. Robledo, E. Kinzie, F. Blanchard, C. Richards, A. Miyajima, H. Baumann, Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J Biol Chem 275, 25273\u201385 (2000)","journal-title":"J Biol Chem"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-011-0011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-011-0011-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-011-0011-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T17:53:30Z","timestamp":1685987610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-011-0011-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,11]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s13402-011-0011-2","relation":{},"ISSN":["2211-3428","1875-8606"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"1875-8606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,11]]}}}